High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial

Lancet
Anoop S V ShahHigh-STEACS investigators

Abstract

High-sensitivity cardiac troponin assays permit use of lower thresholds for the diagnosis of myocardial infarction, but whether this improves clinical outcomes is unknown. We aimed to determine whether the introduction of a high-sensitivity cardiac troponin I (hs-cTnI) assay with a sex-specific 99th centile diagnostic threshold would reduce subsequent myocardial infarction or cardiovascular death in patients with suspected acute coronary syndrome. In this stepped-wedge, cluster-randomised controlled trial across ten secondary or tertiary care hospitals in Scotland, we evaluated the implementation of an hs-cTnI assay in consecutive patients who had been admitted to the hospitals' emergency departments with suspected acute coronary syndrome. Patients were eligible for inclusion if they presented with suspected acute coronary syndrome and had paired cardiac troponin measurements from the standard care and trial assays. During a validation phase of 6-12 months, results from the hs-cTnI assay were concealed from the attending clinician, and a contemporary cardiac troponin I (cTnI) assay was used to guide care. Hospitals were randomly allocated to early (n=5 hospitals) or late (n=5 hospitals) implementation, in which the high-sensiti...Continue Reading

Citations

Nov 10, 2018·Expert Opinion on Drug Safety·Ernest SpitzerPatrick W Serruys
Feb 5, 2019·Annals of Internal Medicine·Katy J L BellAlexandra Barratt
Nov 21, 2018·Critical Reviews in Clinical Laboratory Sciences·Magnus Nakrem LyngbakkenTorbjørn Omland
Nov 23, 2018·Nature Reviews. Cardiology·Till Keller, Christian W Hamm
May 22, 2019·PLoS Medicine·Mohamed S AnwarNicholas L Mills
Aug 31, 2019·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·J W Deckers
Apr 17, 2019·Clinical Chemistry·Jasper BoeddinghausUNKNOWN APACE investigators
Nov 24, 2019·British Journal of Clinical Pharmacology·Marion BennieTanja Mueller
Oct 8, 2019·Circulation·Andrew R ChapmanUNKNOWN High-STEACS Investigators
Oct 2, 2019·Clinical Chemistry·Jasper BoeddinghausUNKNOWN APACE investigators
Jul 25, 2019·Heart·Erik KadesjöMartin J Holzmann
Aug 17, 2019·Circulation·Martin P ThanUNKNOWN MI3 collaborative
Jun 10, 2020·European Heart Journal·John HungMartin J Holzmann
Aug 30, 2020·European Heart Journal·Jean-Philippe ColletUNKNOWN ESC Scientific Document Group
Jul 3, 2019·European Heart Journal. Quality of Care & Clinical Outcomes·Kuan Ken Lee, Anoop S V Shah
Nov 20, 2019·Journal of Clinical Medicine·Samuli JaakkolaK E Juhani Airaksinen
May 30, 2020·British Journal of Hospital Medicine·Elizabeth M Cole, Annemarie B Docherty
Apr 26, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Benjamin L MazerDavid L Rimm
Aug 23, 2019·Journal of the American Heart Association·Amy V FerryNicholas L Mills
Oct 28, 2019·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Chad M ColonFadi G Hage
Dec 21, 2019·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Thomas A KiteAnthony H Gershlick
Nov 28, 2019·Cardiovascular Therapeutics·Giulio Francesco RomitiValeria Raparelli
Apr 2, 2020·Current Cardiology Reports·Michael C Kontos, Jeremy S Turlington
May 9, 2019·Advances in Therapy·Katie LindenIan B A Menown

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Clinical Trials Mentioned

NCT01852123
NCT03005158

Software Mentioned

TrakCare
ARCHITECT

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.